About Boehringer Ingelheim

Join Boehringer Ingelheim and be part of a legacy where your growth is just as important as ours. A global, research-driven pharmaceutical company, we are one of the world’s top 20 leading pharmaceutical companies and havecollaborated and innovated medicines in Human Pharma, Animal Health and Biopharmaceutical everywhere in the world for over 130 years. This is your chance to create ‘Value through Innovation’ with our internal and external partners to improve lives around the world, explore new scientific breakthroughs to stay at the forefront of our industry, and become a leader for future generations.

We continue to grow fast and are one of the top growing companies in the industry in China. Join us and be part of our continued journey to grow and achieve BI global Ambition 2025:

As a leading company, Boehringer Ingelheim thrives on passion, innovation and independence, and offers fulfilling work and growing opportunities to highly dedicated people. Certified as Top Employer in China in the past 5 continuous years, we help our people grow towards their success through high quality career development programmes and opportunities to lead international projects to develop into a leader of tomorrow. At the end of the day, your growth is our growth and vice versa.

For more information, please

1. visit https://www.boehringer-ingelheim.com/ or

2. follow us on LinkedIn, or

3. follow us on WeChat – JoinBI

With global presence, Boehringer Ingelheim has industry-leading expertise in medicine research and development. We are constantly developing the next generation of medical breakthroughs and successfully delivering innovations to meet the medical needs of the patients we serve in the following key areas of interest: cardiovascular, respiratory, metabolic diseases, immunology, oncology and central nervous system.

Our innovative medicines include those for COPD, hypertension, stroke, atrial fibrillation-related stroke prevention, Parkinson’s disease, diabetes and non-small cell lung cancer. In the future, we will accelerate the launch of more than 10 innovative medicines to meet the demand of Chinese patients. This vision is supported by industry-leading levels of investment. This includes more than a hundred R&D pipeline projects, around 50% of early- to mid-stage pipeline anchored in external innovation (2016), and around 20% of net revenue invested in R&D (2016) at a global level. Meanwhile, as one of the Company’s strategic pillars in China, Research Beyond Borders (RBB) explores emerging science, indications and technologies to expand R&D opportunities in China, and even the entire Asia.

If you think you can convince us that you are the right candidate we are looking for, apply now!